Atlas Trials

Effects of the V1a Agonist FE 202158 in Patients With Septic Shock

Clinical trial NCT01000649 · COMPLETED

Trial details

NCT number
NCT01000649
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Septic Shock
Start date
2009-11-01
Primary completion
2011-08-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.